<!DOCTYPE html>
<html>
  <head>
    <meta charset="utf-8">
    <title></title>
    <link rel="stylesheet" href="../../css/uswds.min.css">
    <link rel="stylesheet" href="../../css/style.css">
    <link rel="stylesheet" href="../css/uswds.min.css">
    <link rel="stylesheet" href="../css/style.css">
    <link rel="stylesheet" href="css/uswds.min.css">
    <link rel="stylesheet" href="css/style.css">
  </head>
  <body>

    <header>
        <h2 class="title">
            <a href="/">Code of Federal Regulations (alpha)</a>
        </h2>
    </header>

    <div class="usa-grid">
      <div class="usa-width-one-whole">
          <h3>
                                <a href="/">CFR</a><span>&nbsp/&nbsp</span>
                                <a href="/html/titles/title10.html">
                                    Title 10
                                </a><span>&nbsp/&nbsp</span>
                                <a href="/html/parts/10CFR35.html">Part 35
                                </a><span>&nbsp/&nbsp<span>
                                Sec. 35.392  Training for the oral administration of sodium iodide to 1.22 gigabecquerels (33 millicuries).
                            </h3>
                            <p class="depth0">Except as provided in Sec. 35.57, the licensee shall require an authorized user for the oral administration of sodium iodide I-131 requiring a written directive in quantities less than or equal to 1.22 Gigabecquerels (33 millicuries), to be a physician who--</p><p class="depth1"><em>(a)</em> Is certified by a medical specialty board whose certification process includes all of the requirements in paragraphs (c)(1) and (c)(2) of this section and whose certification process has been recognized by the Commission or an Agreement State and who meets the requirements in paragraph (c)(3) of this section. (The names of board certifications which have been recognized by the Commission or an Agreement State will be posted on the NRC's Web page.); or</p><p class="depth1"><em>(b)</em> Is an authorized user under Sec. 35.390 for uses listed in Sec. 35.390(b)(1)(ii)(G)(1) or (2), Sec. 35.394, or equivalent Agreement State requirements; or</p><p class="depth1"><em>(c)(1)</em> Has successfully completed 80 hours of classroom and laboratory training, applicable to the medical use of sodium iodide I-131 for procedures requiring a written directive. The training must include--</p><p class="depth2"><em>(1)</em> Has successfully completed 80 hours of classroom and laboratory training, applicable to the medical use of sodium iodide I-131 for procedures requiring a written directive. The training must include--</p><p class="depth3"><em>(i)</em> Radiation physics and instrumentation;</p><p class="depth3"><em>(ii)</em> Radiation protection;</p><p class="depth3"><em>(iii)</em> Mathematics pertaining to the use and measurement of radioactivity;</p><p class="depth3"><em>(iv)</em> Chemistry of byproduct material for medical use; and</p><p class="depth3"><em>(v)</em> Radiation biology; and</p><p class="depth2"><em>(2)</em> Has work experience, under the supervision of an authorized user who meets the requirements in Secs. 35.57, 35.390, 35.392, 35.394, or equivalent Agreement State requirements. A supervising authorized user who meets the requirements in Sec. 35.390(b) must also have experience in administering dosages as specified in Secs. 35.390(b)(1)(ii)(G)(1) or 35.390(b)(1)(ii)(G)(2). The work experience must involve--</p><p class="depth3"><em>(i)</em> Ordering, receiving, and unpacking radioactive materials safely and performing the related radiation surveys;</p><p class="depth3"><em>(ii)</em> Performing quality control procedures on instruments used to determine the activity of dosages and performing checks for proper operation of survey meters;</p><p class="depth3"><em>(iii)</em> Calculating, measuring, and safely preparing patient or human research subject dosages;</p><p class="depth3"><em>(iv)</em> Using administrative controls to prevent a medical event involving the use of byproduct material;</p><p class="depth3"><em>(v)</em> Using procedures to contain spilled byproduct material safely and using proper decontamination procedures; and</p><p class="depth3"><em>(vi)</em> Administering dosages to patients or human research subjects, that includes at least 3 cases involving the oral administration of less than or equal to 1.22 gigabecquerels (33 millicuries) of sodium iodide I-131; and</p><p class="depth2"><em>(3)</em> Has obtained written attestation that the individual has satisfactorily completed the requirements in paragraphs (c)(1) and (c)(2) of this section, and has achieved a level of competency sufficient to function independently as an authorized user for medical uses authorized under Sec. 35.300. The written attestation must be signed by a preceptor authorized user who meets the requirements in Secs. 35.57, 35.390, 35.392, 35.394, or equivalent Agreement State requirements. A preceptor authorized user, who meets the requirement in Sec. 35.390(b), must also have experience in administering dosages as specified in Secs. 35.390(b)(1)(ii)(G)(1) or 35.390(b)(1)(ii)(G)(2).
[67 FR 20370, Apr. 24, 2002, as amended at 68 FR 75389, Dec. 31, 2003; 70 FR 16364, Mar. 30, 2005; 71 FR 15009, Mar. 27, 2006; 74 FR 33905, July 14, 2009]</p>
      </div>
    </div>

    <footer class="usa-footer usa-footer-slim" role="contentinfo">
    <div class="usa-grid usa-footer-return-to-top">
      <a href="#">Return to top</a>
    </div>
    <div class="usa-footer-primary-section">
      <div class="usa-grid-full">
        <h5>Built with ‚ù§ by <a href="https://18f.gsa.gov/">18F</a>. Code available <a href="#">on Github.</a></h5>
      </div>
    </div>
  </footer>
  </body>
</html>
